Cyclooxygenase Inhibitor Associated with Carboplatin in Treatment of Metastatic Nasal Carcinoma in Dog

Cyclooxygenase Inhibitor Associated with Carboplatin in Treatment of Metastatic Nasal Carcinoma in Dog

A 10-year-old, intact male, pinscher was presented with unilateral bloodstained nasal discharge, sneezing, dyspnea, zygomatic arch deformity, submandibular lymph node increase, blindness in right eye, and exophthalmia. After clinical examination, it was found that the animal presented with upper res...

Full description

Bibliographic Details
Main Authors:	Carlos Eduardo Fonseca-Alves, Aline Gonçalves Corrêa, Fabiana Elias, Sabryna Gouveia Calazans
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Case Reports in Veterinary Medicine
Online Access:	http://dx.doi.org/10.1155/2014/817930

Similar Items

Adjuvant Low Dose Carboplatin-based Chemotherapy to Treat Metastatic Mammary Carcinomas in Dogs
by: Ya-Ting Chang, et al.
Published: (2019)

Clinicopathological and immunohistochemical evaluation of oesophageal leiomyosarcoma in a dog
by: Renata Cintra Ciccone Alves, et al.
Published: (2015-09-01)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
by: Jun Zhang, et al.
Published: (2011-01-01)

Sequential Combination Chemotherapy of Dacarbazine (DTIC) with Carboplatin and Paclitaxel for Patients with Metastatic Mucosal Melanoma of Nasal Cavity and Paranasal Sinuses
by: W. Omata, et al.
Published: (2017-01-01)

Análise mutacional do gene supressor de tumor TP53 e imunorreatividade da p53 em linfomas caninos
by: Calazans, Sabryna Gouveia [UNESP]
Published: (2014)

Study of molecular simulation Cyclooxygenase-1 and Cyclooxygenase-2 Inhibitors
by: Pin-chen Liu, et al.
Published: (2008)

The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma.
by: Marília Carneiro Machado, et al.
Published: (2018-01-01)

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
by: Han Jae, et al.
Published: (2008-11-01)

COMPARISON BETWEEN GEMCITABINE-CARBOPLATIN AND COMBINATION OF GEMCITABINE-CARBOPLATIN AND CELECOXIB IN UROTHELIAL CARCINOMA CELL APOPTOSIS
by: Widya Sakti Pratama, et al.
Published: (2019-01-01)

Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
by: Yuri Ueda, et al.
Published: (2020-10-01)

201 Carboplatin, paclitaxel and pembrolizumab for the first line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma
by: Alain Algazi, et al.
Published: (2020-11-01)

Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma
by: Furubayashi N, et al.
Published: (2020-10-01)

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
by: Camp Robert L, et al.
Published: (2007-01-01)

Endoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cells.
by: Anamaria Brozovic, et al.
Published: (2013-01-01)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012-10-01)

Cyclooxygenase-2 inhibitors: promise or peril?
by: Laurel J. Mengle-Gaw, et al.
Published: (2002-01-01)

Effects of cyclooxygenase inhibitors on homocysteine metabolism
by: Yan-Jun Lin, et al.
Published: (2011)

Ciclooxygenase inhibitor and metronomic chemotherapy association for the treatment of metastatic anal sac carcinoma in dog: case report
by: N.C.T. Teixeira, et al.
Published: (2016-08-01)

Primary fibrosarcoma im small intestine of dog - Case report
by: Geórgia Modé Magalhães, et al.
Published: (2015-06-01)

Juvenile cellulitis in a puppy – case reports<br>Celulite juvenil canina – relato de casos
by: Carlos Eduardo Fonseca-Alves, et al.
Published: (2012-08-01)

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer
by: Abdel Kader Y, et al.
Published: (2013-06-01)

Randomized Phase II Study with Cetuximab in Combination with 5-FU and Cisplatin or Carboplatin vs. Cetuximab in Combination with Paclitaxel and Carboplatin for Treatment of Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck (CETMET Trial)
by: Georgios Tsakonas, et al.
Published: (2020-10-01)

Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma.
by: Annette Pflugfelder, et al.
Published: (2011-01-01)

A Rare Cause of Nasal Obstruction: Metastatic Renal Cell Carcinoma
by: Tuba Dilay Kokenek-Unal, et al.
Published: (2016-01-01)

Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma
by: Lv X, et al.
Published: (2016-08-01)

Cardiovascular risk and inhibition of cyclooxygenase: traditional nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors
by: M. Campanini, et al.
Published: (2013-05-01)

Cyclooxygenase-1-selective inhibitor SC-560
by: Charles D. Loftin, et al.
Published: (2009-02-01)

Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells
by: Anja-Kristina Brust, et al.
Published: (2008-01-01)

Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells
by: Anja-Kristina Brust, et al.
Published: (2008-01-01)

Antiproliferative Benzoindazolequinones as Potential Cyclooxygenase-2 Inhibitors
by: Aurora Molinari, et al.
Published: (2019-06-01)

Cyclooxygenase-2 inhibitors and knee prosthesis surgery
by: Meunier, Andreas
Published: (2008)

Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
by: Songthong Anussara, et al.
Published: (2015-06-01)

The antitumor immunity of FasL-transfected Lewis lung carcinoma enhanced by cyclooxygenase-2 inhibitor
by: Ren-Shiang Jhou, et al.
Published: (2004)

Phase 1 study of one-week chemotherapy with paclitaxel and carboplatin in patients with metastatic bladder cancer
by: M. Johansen, et al.
Published: (2020-02-01)

The Role of Cyclooxygenase-2 in Models of Epilepsy and Traumatic Brain Injury : Effects of Selective Cyclooxygenase-2 Inhibitors
by: Kunz, Tina
Published: (2002)

Characterization of the nasal and oral microbiota of detection dogs.
by: Anitha Isaiah, et al.
Published: (2017-01-01)

Die antioxidative Wirkung von Cyclooxygenase-2-Hemmern gemessen an Miniorgankulturen nasaler Schleimhaut
by: Schuster, Marie-Therese
Published: (2009)

Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study
by: Laura E. Barrett, et al.
Published: (2019-08-01)

Exploiting the synergy between carboplatin and ABT-737 in the treatment of ovarian carcinomas.
by: Harsh Vardhan Jain, et al.
Published: (2014-01-01)

nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma
by: Go Makimoto, et al.
Published: (2014-01-01)